Januvia Pancreatic Cancer Lawsuit To Be Decided By Jury, Illinois Appeals Court Determines
An Illinois appeals court has reinstated two Januvia lawsuits, saying that juries must decide failure to warn claims over pancreatic cancer risks.…
«
»
An Illinois appeals court has reinstated two Januvia lawsuits, saying that juries must decide failure to warn claims over pancreatic cancer risks.…
A new study warns that older diabetes drugs may increase the risk of heart problems, and suggests doctors use newer medications as second-line treatments.…
Another study appears to link Invokana and similar diabetes drugs with an increased risk of leg and foot amputations.…
A growing number of lawsuits over claims that Byetta, Victoza and similar diabetes drugs can cause pancreatic cancer are being filed in the wake of a recent decision to reinstate the litigation.…
A new schedule for Byetta, Januvia and Victoza pancreatic cancer lawsuits sets the first bellwether trial for January 2020.…
More than 700 Victoza, Byetta, Januvia and Janumet pancreatic cancer lawsuits have been reinstated by a federal appeals court, overturning a summary judgment that led to their dismissal in 2015.…
A new study highlights the diabetic ketoacidosis risk with Invokana, indicating that users of the new generation diabetes drug may be twice as likely to develop this dangerous build up of acid levels in the blood.…
The findings of a new study suggest that there is little difference between a variety of diabetes drugs currently on the market, despite a wide range of risks.…
A popular class of diabetes drugs may be causing blood glucose levels to drop too low in some diabetics, resulting in an increased risk of hypoglycemic health problems, according to the findings of a new study.…
Two new studies find no evidence of heart failure risk associated with Onglyza and Januvia, contradicting some previous studies and an FDA warning.…